FAKTOR-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000SW1ERT5

Delayed Deutsche Boerse AG 07:44:03 2024-05-24 EDT
0.57 EUR -52.10% Intraday chart for FAKTOR-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-18.49%
1 month-15.00%
Date Price Change
24-05-24 0.57 -52.10%
24-05-23 1.19 +12.26%
24-05-22 1.06 +17.78%
24-05-21 0.9 +9.76%
24-05-20 0.82 +2.50%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 07:44 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SW1ERT
ISINDE000SW1ERT5
Date issued 2023-07-25
Strike 48.9
Maturity Unlimited
Parity 1 : 1
Emission price 10.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 87.33
Lowest since issue 0.57
Spread 0.03
Spread %4.76%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.38 EUR
Average target price
39.84 EUR
Spread / Average Target
+3.81%
Consensus